Changing from whole-cell to acellular pertussis vaccines would trade superior tolerability for inferior protection

References

• UNICEF Supplies and Logistics. Vaccines supplied for GAVI, the Vaccine Alliance. 2015. Available from: http://www.unicef.org/supply/files/DTP-HepB-Hib.pdf [Last accessed 17 June 2015]
   Google Scholar
• WHO. Global advisory committee on vaccine safety, 12–13 June 2013. Wkly Epidemiol Rec 2013;88:301-12
   PubMedGoogle Scholar
• GAVI, The Vaccine Alliance. Pentavalent vaccine support 2015. Available from: http://www.gavi.org/support/nvs/pentavalent/ [Last accessed 23 May 2015]
   Google Scholar
• GAVI, The Vaccine Alliance. Program and Policy Committee 5-6 May 2014 meeting minutes. Available from: http://www.gavi.org/library/minutes/ [Last accessed 23 May 2015]
   Google Scholar
• WHO. Revised guidance on the choice of pertussis vaccines – July 2014. Wkly Epidemiol Rec 2014;89:337-40
   PubMedGoogle Scholar
• Edwards KM. Unravelling the challenges of pertussis. Proc Nat Acad Sci USA 2014;111:575-6
   PubMed Web of Science ®Google Scholar
• Sealey KL, Harris SR, Fry NK, et al. Genomic analysis of isolates from the United Kingdom. 2012 pertussis outbreak reveals that vaccine antigen genes are unusually fast evolving. J Infect Dis 2014. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• WHO. Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec 2010;85:385-400. Comprehensive list of references for position paper. Available from: http://www.who.int/immunization/PP_Pertussis_Oct_2010_references.pdf?ua=1 [Last accessed 6 April 2015]
   Google Scholar
• WHO. Pertussis. The Immunological Basis for Immunization Series Module 4: Pertussis Update 2009. 2010. Available from: http://whqlibdoc.who.int/publications/2010/9789241599337_eng.pdf?ua=1&ua=1 [Last accessed 6 April 2015]
   Google Scholar
• Amirthalingam G, Gupta S, Campbell H. Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review. Euro Surveill 2013;18(38):pii=20587
   Google Scholar
• Sheridan SL, Frith K, Snelling TL, et al. Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology. Expert Rev Vaccines 2014;13:1081-106
   PubMed Web of Science ®Google Scholar
• Chitkara AJ, Vashistha VM. Pertussis outbreaks in the developed world: are acellular vaccines ineffective? Indian Pediatr 2013;50:1109-11
   PubMed Web of Science ®Google Scholar
• Chiappini E, Stival A, Galli L, et al. Pertussis re-emergence in the post-vaccination era. BMC Infect Dis 2013;13:151
   PubMed Web of Science ®Google Scholar
• Riolo MA, Rohani P. Combating pertussis resurgence: one booster vaccination schedule does not fit all. Proc Natl Acad Sci USA 2015;112:E472-7
   PubMed Web of Science ®Google Scholar
• Cherry JD. Epidemic pertussis and acellular pertussis vaccine failure in the 21st century. Pediatrics 2015;135:1130-2
   PubMed Web of Science ®Google Scholar
• Plotkin SA. The pertussis problem. Clin Infect Dis 2014;58:830-3
   PubMed Web of Science ®Google Scholar
• Plotkin SA. Complex correlates of protection after vaccination. Clin Infect Dis 2013;56:1458-65
   PubMed Web of Science ®Google Scholar
• WHO. Meeting of the Strategic Advisory Group of Experts on immunization, April 2014 - conclusions and recommendations. Wkly Epidemiol Rec 2014;89:221-36
   PubMedGoogle Scholar
• Klein NP, Bartlett J, Fireman B, et al. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers. Pediatrics 2013;131:e1716-22
   PubMed Web of Science ®Google Scholar
• Koepke R, Eickhoff JC, Ayele RA, et al. Estimating the effectiveness of Tdap vaccine for preventing pertussis: evidence of rapidly waning immunity and differences in effectiveness by Tdap brand. J Infect Dis 2014;210:942-53
   PubMed Web of Science ®Google Scholar
• Acosta AM, DeBolt C, Tasslimi A, et al. Tdap vaccine effectiveness in adolescents during the 2012 Washington state pertussis epidemic. Pediatrics 2015;135:981-9
   PubMed Web of Science ®Google Scholar
• McGirr A, Fisman DN. Duration of pertussis immunity after DTaP immunization: a meta-analysis. Pediatrics 2015;135:331-43
   PubMed Web of Science ®Google Scholar
• Tartof SY, Lewis M, Kenyon C, et al. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics 2013;131:e1047-52
   PubMed Web of Science ®Google Scholar
• Quinn HE, Snelling TL, Macartney KK, et al. Duration of protection after first dose of acellular pertussis vaccine in infants. Pediatrics 2014;133:e513-19
   PubMed Web of Science ®Google Scholar
• Aase A, Herstad TK, Jorgensen SB, et al. Anti-pertussis antibody kinetics following DTaP-IPV booster vaccination in Norwegian children 7–8 years of age. Vaccine 2014;32:5931-6
   PubMed Web of Science ®Google Scholar
• Mawas F, Dickinson R, Douglas-Bardsley A, et al. Immune interaction between components of acellular pertussis-diphtheria-tetanus (DTaP) vaccine and Haemophilus influenzae b (Hib) conjugate vaccine in a rat model. Vaccine 2006;24:3505-12
   PubMed Web of Science ®Google Scholar
• Wu Y, Gao Y, Zhu B, et al. Antitoxins for diphtheria and tetanus decline more slowly after vaccination with DTwP than with DTaP: A study in a Chinese population. Vaccine 2014;32:2570-3
   PubMed Web of Science ®Google Scholar
• Sheridan SL, Ware RS, Grimwood K, et al. Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA 2012;308:454-6
   PubMed Web of Science ®Google Scholar
• Witt MA, Arias L, Katz PH, et al. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort. Clin Infect Dis 2013;56:1248-54
   PubMed Web of Science ®Google Scholar
• Liko J, Robison SG, Cieslak PR. Priming with whole-cell versus acellular pertussis vaccine. New Engl J Med 2013;368:581-2
   PubMed Web of Science ®Google Scholar
• Haller S, Dehnert M, Karagiannis I, et al. Effectiveness of routine and booster pertussis vaccination in children and adolescents, federal State of Brandenburg. Germany, 2002-2012. Ped Infect Dis J 2015;34:513-19
   Google Scholar
• Hallander H, Advani A, Alexander F, et al. Antibody responses to Bordetella pertussis Fim2 or Fim3 following immunization with a whole-cell, two-component, or five-component acellular pertussis vaccine and following pertussis disease in children in Sweden in 1997 and 2007. Clin Vaccine Immunol 2014;21:165-73
   PubMed Web of Science ®Google Scholar
• Bart MJ, Harris SR, Advani A, et al. Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio 2014;5(2):e01074-14
   PubMed Web of Science ®Google Scholar
• Hegerle N, Guiso N. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines. Expert Rev Vaccines 2014;13:1135-46
   PubMed Web of Science ®Google Scholar
• Pawloski LC, Queenan AM, Cassiday PK, et al. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. Clin Vaccine Immunol 2014;21:119-25
   PubMed Web of Science ®Google Scholar
• Hegerle N, Dore G, Guiso N. Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine. Vaccines 2014;32:6597-600
   PubMed Web of Science ®Google Scholar
• Lam C, Octavia S, Ricafort L, et al. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerg Infect Dis 2014;20:626-33
   PubMed Web of Science ®Google Scholar
• Queenan AM, Cassiday PK, Evangelista A. Pertactin-neg variants of B. pertussis in the US. New Engl J Med 2013;368:583-4
   PubMed Web of Science ®Google Scholar
• Martin SW, Pawloski L, Williams M, et al. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage. Clin Infect Dis 2015;60:223-7
   PubMed Web of Science ®Google Scholar
• Bamberger E, Raya BA, Cohen L, et al. Pertussis resurgence associated with pertactin-Deficient and genetically divergent bordetella pertussis isolates in Israel. Pediatr Infect Dis J 2015. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Zeddeman A, van Gent M, Heuvelman CJ, et al. Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012. Euro Surveill 2014;19(33):pii=20881
   Google Scholar
• de Cellès MD, Riolo MA, Magpantay FMG, et al. Epidemiological evidence for herd immunity induced by acellular pertussis vaccines. Proc Natl Acad Sci USA 2014;111:E716-17
   PubMed Web of Science ®Google Scholar
• Carlsson RM, von Segebaden K, Bergström J, et al. Surveillance of infant pertussis in Sweden 1998-2012; severity of disease in relation to the national vaccination Programme. Euro Surveill 2015;20(6):pii=21032
   Google Scholar
• Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci USA 2014;111:787-92
   PubMed Web of Science ®Google Scholar
• Smallridge WE, Rolin OY, Jacobs NT, et al. Different effects of whole cell and acellular vaccines on Bordetella transmission. J Infect Dis 2014;209:1981-8
   PubMed Web of Science ®Google Scholar
• Heininger U. Pertussis: what pediatric infectious diseases specialists should know. Ped Infect Dis J 2012;31:78-9
   PubMed Web of Science ®Google Scholar
• Thorstensson R, Trollfors B, Al-Tawil N, et al. A phase I clinical study of a live attenuated Bordetella pertussis vaccine – BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. PLoS One 2014;9:e83449
   Google Scholar
• Locht C, Mielcarek N. Live attenuated vaccines against pertussis. Expert Rev Vaccines 2014;13:1147-58
   PubMed Web of Science ®Google Scholar
• Allen AC, Mills KHG. Improved pertussis vaccines based on adjuvants that induce cell-mediated immunity. Expert Rev Vaccines 2014;13:1253-64
   PubMed Web of Science ®Google Scholar
• Robbins JB, Schneerson R, Kubler-Kielb J, et al. Toward a new vaccine for pertussis. Proc Natl Acad Sci USA 2014;111:3213-16
   PubMed Web of Science ®Google Scholar
• Thierry-Carstensen B, Dalby T, Stevner MA, et al. Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults – a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience. Vaccine 2013;31:5178-91
   PubMed Web of Science ®Google Scholar
• Snelling TL, Waddington CS. Whither pertussis? Expert Rev Anti Infect Ther 2015;13:145-8
   PubMed Web of Science ®Google Scholar
• Tiwari TSP, Baughman AL, Clark TA. First pertussis vaccine dose and prevention of infant mortality. Pediatrics 2015;135:990-9
   PubMed Web of Science ®Google Scholar
• Swamy GK, Wheeler SM. Neonatal pertussis, cocooning and maternal immunization. Expert Rev Vaccines 2014;13:1107-14
   PubMed Web of Science ®Google Scholar
• Forsyth K, Plotkin S, Tan T, et al. Strategies to decrease pertussis transmission to infants. Pediatrics 2015;135:e1475-82
   PubMed Web of Science ®Google Scholar
• Amirthalingam G, Andrews N, Campbell H, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014;384:1521-8
   PubMed Web of Science ®Google Scholar
• Dabrera G, Amirthalingam G, Andrews N, et al. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales. 2012-2013. Clin Infect Dis 2015;60:333-7
   PubMed Web of Science ®Google Scholar
• Warfel JM, Papin JF, Wolf RF, et al. Maternal and neonatal vaccination protects newborn baboons from pertussis infection. J Infect Dis 2014;210:604-10
   PubMed Web of Science ®Google Scholar
• Quinn HE, Snelling TL, Habig A, et al. Parental Tdap boosters and infant pertussis: a case-control study. Pediatrics 2014;134:713-20
   PubMed Web of Science ®Google Scholar
• Healy CM, Rench MA, Wootton SH, et al. Evaluation of the impact of a pertussis cocooning program on infant pertussis infection. Pediatr Infect Dis J 2015;34:22-6
   PubMed Web of Science ®Google Scholar
• Carollo M, Pandolfi E, Tozzi AE, et al. Humoral and B-cell memory responses in children five years after pertussis acellular vaccine priming. Vaccine 2014;32:2093-9
   PubMed Web of Science ®Google Scholar
• Hallander HO, Nilsson L, Gustafsson L. Is adolescent pertussis vaccination preferable to natural booster infections? Expert Rev Clin Pharmacol 2011;4:705-11
   PubMedGoogle Scholar
• Heininger U, Weibel D, Richard J-L. Prospective nationwide surveillance of hospitalizations due to pertussis in children. 2006-2010. Pediatr Infect Dis J 2014;33:147-51
   PubMed Web of Science ®Google Scholar